Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung?

G. Shepherd (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), O. Castro (Oxford, United Kingdom), R. Varatharajah (Oxford, United Kingdom), A. Thayanandan (Oxford, United Kingdom), Q. Lu (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), D. Mccracken (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), M. Tsikrika (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)

Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Session: Novel approaches to pleural effusion: should I change my practice?
Session type: Oral Presentation
Number: 492
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Shepherd (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), O. Castro (Oxford, United Kingdom), R. Varatharajah (Oxford, United Kingdom), A. Thayanandan (Oxford, United Kingdom), Q. Lu (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), D. Mccracken (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), M. Tsikrika (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom). Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung?. 492

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of concomitant pleural effusions in patients with lung cancers
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007

Diagnosis of malignant pleural effusions; cytology or biopsy?
Source: Eur Respir J 2004; 24: Suppl. 48, 72s
Year: 2004

Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006

Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Management of recurrent malignant pleural effusions
Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques
Year: 2019

Management of recurrent malignant pleural effusions
Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques, April 2019
Year: 2019

Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2016 - Thoracoscopy and pleural techniques
Year: 2016

Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2017 - Thoracoscopy and Pleural Techniques
Year: 2017

Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2016
Year: 2016

Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2018 - Thoracoscopy and pleural techniques
Year: 2018

Thoracoscopy in malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 611s
Year: 2006

Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Malignant pericardial effusion in lung cancer patients
Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Year: 2006

Prognosis of patients with NSCLC undergoing positive pleural lavage cytology
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008


The role of surgery in cytologically positive pleural effusion in NSCLC
Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors
Year: 2003


Are patients with malignant pleural effusions being referred appropriately for surgical intervention?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008


Malignant pleural disease in primary lung cancer
Source: Eur Respir Mon; 2009: 44: 318–335
Year: 2009

Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006